Latest News

Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

  • July 01, 2019 12:46 PM | Grant Dvorak (Administrator)

    July 1, 2019, Pharmacy Times 

    Officials with the U.S. Food and Drug Administration have approved bevacizumab-bvzr (Zirabev, Pfizer), a biosimilar to bevacizumab (Avastin), for the treatment of five types of cancer, according to a press release. Bevacizumab-bvzr is indicated for the treatment of metastatic colorectal cancer; unresectable, locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer (NSCLC); recurrent glioblastoma; metastatic renal cell carcinoma (RCC); and persistent, recurrent or metastatic cervical cancer. 

    Read more.

  • July 01, 2019 12:42 PM | Grant Dvorak (Administrator)

    July 1, 2019, Medscape 

    Fewer than 40% of people in the United States have ever been tested for HIV, according to a report from the Centers for Disease Control and Prevention published June 27 in Morbidity and Mortality Weekly Report.

    National HIV Testing Day, on June 27, acknowledges the vital role of testing in preventing, detecting, and treating HIV infection. Early diagnosis is critical to controlling transmission. Those who test negative but are at elevated risk can employ preexposure prophylaxis.

    Since 2006, CDC has recommended universal screening for HIV infection at least once in a healthcare setting for people aged 13 to 64 years and at least annual rescreening of individuals at increased risk. 

    Read more.

  • June 30, 2019 11:28 AM | Grant Dvorak (Administrator)

    June 30, 2019, MedPage Today 

    Use of intracytoplasmic sperm injection (ICSI) in cases without male infertility held no advantages over conventional in vitro fertilization (IVF), according to a pair of retrospective European studies. 

    Read more.

  • June 28, 2019 9:43 AM | Grant Dvorak (Administrator)

    June 28, 2019, Association for Professionals in Infection Control via Medical Xpress  

    Hospitalwide introduction of new female external catheter technology halved the number of catheter-associated urinary tract infections (CAUTIs) according to new research presented last week in Philadelphia at the 46th Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC). 

    Read more.

  • June 28, 2019 9:35 AM | Grant Dvorak (Administrator)

    June 28, 2019, HealthDay News 

    HPV vaccination programs significantly reduce human papillomavirus infections and precancerous cervical lesions, a new global review finds.

    Vaccination protects against the HPV strains that cause the majority of cervical cancers.

    Researchers analyzed 65 studies that included data collected over eight years from more than 60 million people in 14 high-income countries. 

    Read more.

  • June 28, 2019 9:34 AM | Grant Dvorak (Administrator)

    June 28, 2019, Medpage Today 

    The final analysis of a major trial in advanced ovarian cancer continued to show no survival improvement with the addition of bevacizumab (Avastin) to chemotherapy, 9 years after the initial analysis showed no survival benefit.

    Read more.

  • June 28, 2019 9:32 AM | Grant Dvorak (Administrator)

    June 28, 2019, MedPage Today 

    New recommendations for human papillomavirus (HPV) and 13-valent pneumococcal conjugate (PCV13, Prevnar) vaccines emerged from the CDC's Advisory Committee for Immunization Practices (ACIP) meeting in Atlanta on Wednesday. 

    Read more.

  • June 27, 2019 9:46 AM | Grant Dvorak (Administrator)

    June 27, 2019, Medscape 

    Consuming processed foods during pregnancy may be linked to an increased risk for autism spectrum disorder (ASD) in offspring, preliminary research suggests. Investigators from the University of Central Florida (UCF) College of Medicine in Orlando found that high levels of propionic acid (PPA) — used in processed foods to extend shelf life — alters neuronal development in the fetal brain. 

    Read more.

  • June 25, 2019 4:24 PM | Grant Dvorak (Administrator)

    June 25, 2019, Primary Care 

    One treatment that's remained both relevant and important for women struggling with abnormal uterine bleeding (AUB) is global endometrial ablation (GEA), a minimally invasive procedure involving the removal of the uterine lining via radiofrequency, heat or cryotherapy. Endometrial ablation is an important option to offer patients for several reasons, but a primary advantage is that it fills a gap left open for those patients who do not want to be treated with hormone therapy (or do not respond) but want to avoid the costs, potential complications and recovery time associated with major surgery via a hysterectomy. 

    Read more.

  • June 24, 2019 9:20 AM | Grant Dvorak (Administrator)

    June 24, 2019, STAT 

    Drug companies, politicians, hospitals, clinicians and patients all agree that there isn't nearly enough information about whether a given medicine is safe for pregnant and breastfeeding women to use or whether it will work. A sweeping new effort in Europe aims to change that by bringing all of those groups together to address a public health issue they say demands urgent attention.

    Read more.

Powered by Wild Apricot Membership Software